Researcher identifies new biomarker of early-stage Alzheimer's disease

University of New Mexico neurologist Rawan Tarawneh, MD, has identified a unique biomarker that could lead to new diagnostic tests to improve the detection of incipient Alzheimer’s disease before symptoms appear.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup